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Abstract 
JONATHAN M. RESIDE:  In vivo Assessment of Bone Healing Following Piezotome® 
Ultrasonic Instrumentation 
(Under the direction of Salvador Nares, D.D.S., Ph.D., Eric Everett, M.S. Ph.D., 
Ricardo Padilla, D.D.S.) 
The first part of this thesis details a randomized controlled study in which 
osteotomies were prepared in the tibia of 15 rats using either 1st or 2nd Generation 
Piezotome® ultrasonic surgical units, or high speed rotary instrumentation.  Sham surgeries 
were performed as controls.  Real-time reverse transcriptase polymerase chain reaction was 
completed, highlighting differential gene expression patterns at 1 week post-surgery while 
immunohistochemistry staining for matrix metalloproteinase 2, matrix metalloproteinase 8, 
and tumor necrosis factor-α compared the localization of gene expression at 1 and 3 weeks 
post-surgery.  The second part details a second randomized control study in which 
osteotomies were prepared in the tibia of 9 rats using the same instrumentation methods.  
Three weeks post-surgery, micro-computer tomography was completed to evaluate bone 
mineral density and percentage of bone fill within the osteotomy defects and peripheral bone.  
Qualitative histological characterization of the tissues was also completed at 3 weeks.  
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PART I:  
  
GENETIC EXPRESSION PROFILES FOLLOWING IN VIVO BONE 
INSTRUMENTATION WITH PIEZOTOME® ULTRASONIC  
SURGICAL UNITS 
Abstract 
 The aim of this study is to evaluate differences in the genetic expression following the 
use of piezoelectric and rotary instrumentation for osteotomy preparation.  Fourteen Sprague-
Dawley rats underwent bilateral tibial osteotomies (n=28) prepared in a randomized split-leg 
design using either high speed rotary (R), 1st Generation Piezotome® (P1), or 2nd Generation 
Piezotome® (P2) instrumentation.  Sham surgeries (S) served as controls.  At 1 week, tibiae 
(n=12) were resected and processed for qRT-PCR array analysis.  Osteotomies were also 
subject to immunohistochemistry for MMP2, MMP8, and TNF-α at 1 week and 3 weeks 
(n=8 each week).  At 1 week, expression of 11 and 18 genes important in bone healing were 
significantly (p<0.05) decreased following P1 and P2 instrumentation, respectively, relative 
to S.  Qualitative evaluation of immunohistochemistry confirmed cell positivity within the 
healing tissues.  Variations in gene expression important to osseous wound healing suggest 
differences in healing rates due to surgical modality. 
  
  
INTRODUCTION 
 
Piezoelectric surgical units have been used in a variety of surgical treatments, 
including lateral window sinus lift techniques (Sohn et al., 2009; Vercellotti, De Paoli, & 
Nevins, 2001; Wallace et al., 2007), autogenous bone grafting (Happe, 2007; Sohn et al., 
2007; Stubinger et al., 2006), implant site preparation (Preti et al., 2007), osteotomy close to 
nerves (Bovi et al., 2010; Geha et al., 2006), extractions (Degerliyurt et al., 2009; Grenga & 
Bovi, 2004), periodontal surgery (Vercellotti & Pollack, 2006), and distraction osteogenesis 
(Gonzalez-Garcia et al., 2008; Lee, Ahn, & Sohn, 2007).  While the use of piezoelectric 
surgical units in dental applications has increased in recent history, little is known regarding 
the cellular and molecular responses of tissues to ultrasonic instrumentation. 
Following insult, bone repair and/or regeneration occurs through the interaction of 
various bone cells, extracellular matrix components, and inorganic minerals.  Bone repair 
undergoes three important phases: an acute inflammatory phase, a reparative phase, and a 
remodeling phase (Lieberman & Friendlaender, 2005).  Endothelial damage as a result of 
injury activates the complement cascade, initiating the inflammatory phase of healing.  
Platelet aggregation also occurs during this phase and these platelets play a complex role in 
the release of growth factors and chemotactic agents, recruiting inflammatory cells such as 
leukocytes, lymphocytes, and macrophages.  Platelets within the osseous defect form a 
hematoma which remodels to form a reparative granuloma, or callus.  The reparative phase 
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of healing involves the formation of this fibroblastic callus to provide mechanical stability 
and serve as a framework for subsequent bone formation through the function of osteoblasts 
and chondroblasts.  Finally, the remodeling phase occurs with the continued maturation of 
the bone over time through coordinated efforts by both osteoclasts and osteoblasts.   
All of these events governing bone healing are coordinated by a number of biological 
processes (Ai-Aql et al., 2008; Einhorn, 1998; Lieberman & Friendlaender, 2005).  These 
processes directing bone repair are tightly regulated by multiple factors, including 
proinflammatory cytokines, members of the transforming growth factor-β (TGF-β) 
superfamily, and angiogenic factors.  Each of these groups has biological activity, including 
the promotion of overlapping biological processes and the orchestration of different 
interactions between differing cell populations.  Inflammatory cytokines, including 
interleukin-1 and -6 (IL-1 and IL-6) and tumor necrosis factor-α (TNF-α), are expressed early 
in the inflammatory phase of bone healing and are predominantly secreted by macrophages 
and other inflammatory cells at the site of tissue injury.  These cytokines serve as important 
factors in the initiation of the repair cascade, the recruitment of additional inflammatory 
cells, the deposition of extracellular matrix, and the stimulation of angiogenesis.  
Mesenchymal stem cells are subsequently recruited by TNF-α and induced to differentiate 
into chondrogenic or osteogenic cells by members of the TGF-β superfamily, including bone 
morphogenetic proteins (BMPs).  A number of BMPs play important roles during this 
reparative phase, including BMP-2, BMP-4, and BMP-6, which serve to further direct 
extracellular matrix deposition and bone formation through the differentiation of 
osteoprogenitor cells.  Expression of other angiogenic factors, such as vascular endothelial 
growth factors (VEGFs) and angiopoietins, are also upregulated during the reparative phase.  
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IL-1, TNF-α, and various BMPs are again upregulated during the remodeling phase in the 
demineralization of immature lamellar bone and subsequent remineralization to more mature 
woven bone.  How these processes are affected by piezoelectric instrumentation is not 
completely known.  Given the increased use of these instruments in clinical applications, it is 
important to understand the impact of ultrasonic instrumentation on osseous healing. 
The purpose of this present study is to compare the genetic response of bone to 
piezoelectric surgical and traditional high speed rotary instrumentation in a rat tibia model.  
We hypothesize that the tissue regenerative response of bone to first- and second-generation 
piezoelectric units is equivalent or better than rotary instrumentation.  We also hypothesize 
that there will be no difference in response to units with different power output capacities. 
 
  
  
MATERIALS AND METHODS 
 
Surgical Procedures 
All experimental procedures followed a protocol approved by the Institutional Animal 
Care and Use Committee at The University of North Carolina at Chapel Hill.  Fourteen male 
Sprague-Dawley rats (Charles River Laboratories International, Inc., Wilmington, MA) 
weighing approximately 250-300g were used for the study for a total of 28 tibiae.  Rats were 
anesthetized with an intraperitoneal injection of ketamine/xylazine and the surgical sites 
shaved and disinfected with Betadine®.  An incision was made along the medial aspect of 
each tibia.  The overlying muscle was gently separated and the periosteum elevated.  Using a 
randomized approach, a 6mm vertical osteotomy (n = 7 tibiae per treatment group) was 
prepared through the cortical bone in the medial aspect of each tibia using copious saline 
irrigation and either (1) the BS1 insert (Satelec Acteon, Merignac, France)  mounted on the 
Piezotome® (Acteon) surgical unit (P1 group), (2) the BS1 insert mounted on the Implant 
Center 2 (Piezotome® 2, Acteon) surgical unit (P2 group), or (3) a ¼  round bur (Brassler 
USA, Savannah, GA) with high speed rotary instrumentation (Implant Center 2, Acteon) (R 
group).  The power and irrigation settings were as follows: P1: Mode 1, 50 mL/min 
irrigation; P2: Mode D1, 60 mL/min irrigation; and R: 200,000 revolutions per minute, 60 
mL/min irrigation.  Surgical sham control surgeries (S group) (n = 7 tibiae) consisted of 
tissue elevation to expose bone for 3-5 minutes (the approximate time for osteotomy 
preparation).  Following surgery, the periosteal/muscle tissues were sutured using 5-0 
chromic gut followed by closing of flaps with 4-0 silk suture. 
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Rats were euthanized by CO2 inhalation at either 1 week (n = 20 tibiae) or 3 weeks (n 
= 8 tibiae) after surgery.  For tibias undergoing genetic analysis, residual muscle or soft 
tissues were carefully removed and the limbs resected at the level of articulation, snap frozen 
in liquid nitrogen, and stored at -80°C.  For immunohistochemistry, postmortem cardiac 
perfusion fixation was completed using 10% neutral buffered formalin (NBF) and tibias were 
isolated at the level of articulation, fixed in 10% NBF for 48 hours, rinsed in phosphate 
buffered saline (PBS), and stored in 70% ethanol at 4°C.   
 
RNA Isolation, Real-Time Reverse Transcriptase PCR 
Tibias were homogenized in liquid nitrogen using a mortar and pestle, total RNA 
extracted using Trizol (Invitrogen, Carlsbad, CA) and further purified using the RNeasy Mini 
Kit (Qiagen, Germantown, MD) according to manufacturer’s instructions.  RNA integrity 
was assessed using a NanoDrop ND-1000 spectrophotometer (NanoDrop Technologies, 
Wilmington, DE) and the 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA).  For 
each sample, synthesis of cDNA was completed from 1 µg of total RNA using the 
Omniscript Kit (Qiagen) and random decamer primers (Applied Biosystems/Ambion, Austin, 
TX) according to manufacturer’s instructions. qRT-PCR was performed using the Rat 
Osteogenesis RT2 Profiler™ PCR Array (SABiosciences, Frederick, MD) on an ABI 
PRISM® 7500 Real-Time PCR Thermal Cycler (Applied Biosystems, Foster City, CA) 
according to manufacturer’s instructions. Cycling conditions included an initial cycle of 2 
min at 50°C and 10 min at 95°C, followed by a 40 cycles of 15 sec at 95 C ° and 1 min at 
60°C.  Each Rat Osteogenesis RT2 Profiler™ PCR Array contained 84 wells with primers for 
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different genes related to skeletal development, bone mineral metabolism, cell growth and 
differentiation, extracellular matrix proteins, transcription factors and regulators, and cell 
adhesion molecules.  RT2 Profiler™ PCR Array Data Analysis software (SABiosciences) 
was used to calculate threshold cycle (Ct) values.  Data was analyzed using the 2-∆∆Ct method 
and results reported as fold change (Livak & Schmittgen, 2001).  Differentially expressed 
genes were subsequently classified by Gene Ontology terms. 
 
Immunohistochemistry 
Automated IHC was performed using the DAKO Autostainer Plus system (DAKO, 
Carpinteria, CA) at room temperature.  Tissues fixed in 10% NBF were rinsed in PBS and 
demineralized by immersion in Immunocal (Decal Chemical Corporation, Tallman, NY) for 
2 weeks at room temperature.  Complete decalcification was confirmed by lack of 
radiopacity using microCT scans (Skyscan, Aartselaar, Belgium).  Tissues were processed 
with routine ethanol dehydrations, xylene clearing, and paraffin infiltrations.  Specimens 
were axially sectioned at a thickness of 5 µm onto subbed glass slides, deparaffinized, 
rehydrated using graded ethanols and finally with distilled water.  After rinsing in running 
water, slides were placed in Tris buffer.   When required, antibody retrieval was completed 
using Pascal retrieval unit (DAKO) and Target retrieval solution, pH 6.0 (DAKO).  Sections 
were exposed to the dual endogenous enzyme block (DAKO) for 10 minutes, rinsed with 
Tris, and blocked with serum free protein (DAKO) for 15 minutes.  Primary antibody 
dilutions for MM2, MMP8, and TNF-α (Abcam Incorporated, Cambridge, MA) were 1:50, 
1:50, and 1:800, respectively.  After 60 minutes, anti-rabbit (MMP8, TNF-α) or anti-mouse 
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(MMP2) secondary antibody (Envision+, DAKO) was applied for 45 minutes followed by  
DAB+ chromagen (DAKO) for an additional 10 minutes.  The slides were counterstained 
with hematoxylin and examined by light microscopy.  The presence and location of staining 
for the different antibodies was described by a blinded examiner.   
 
Statistics 
Statistical analyses of gene expression group differences were identified using the 
web-based RT2 Profiler™ PCR Array Data Analysis program (SABiosciences).  Alpha 
values ≤ 0.05 were used for all tests to indicate statistical significance. 
 
  
  
RESULTS 
 
Real-Time Reverse Transcriptase PCR 
A list of the genes with statistically significant differential expression levels is present 
in Table 1 with corresponding representative biological process Gene Ontology terms.  Of 
the 84 genes examined, 28 had significant differences (p<0.05) in expression when 
comparing P1 and P2 to S (Table 2) while 19 had significant differences (p<0.05) in 
expression when compared to R (Table 3).  Expression of genes involved in a number of 
biological processes related to both osseous wound healing and cellular events important in 
wound healing were diminished relative to S (Figure 1) and R groups (Figure 2). 
When compared to S (Table 2), decreased expression of 3 genes (Comp, Smad3, 
Vegfa) and increased expression of 1 gene (Col3a1) was noted in the R group.  In 
comparison, the expression of 18 (Bmpr1a, Col4a1, Col5a1, Col6a1, Col12a1, Col14a1, 
Fgfr1, Fn1, Gdf10, Igf1, Itgav, Itgb1, Mmp2, Scarb1, Smad1, Tgfb3, Tnf, Tuft1) and 11  
(Bmp6, Bmp7, Bmpr1a, Col14a1, Gdf10, Igf1r, Itga3, Itgam, Mmp8, Smad1, Tuft1) genes 
were significantly decreased in the P1 and P2 groups, respectively, relative to S.  No genes 
were significantly upregulated following P1 or P2 instrumentation relative to S. 
When R was used as a reference group, 16 genes (Anxa5, Bgn, Bmp4, Col3a1, 
Col4a1, Col5a1, Col6a1, Col12a1, Col14a1, Igf1, Itgav, Itgb1, Msx1, Scarb1, Smad1, 
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Tgfbr3) had statistically significant decreases in expression following instrumentation with 
P1 compared to 4 genes (Col14a1, Itgam, Tgfb1, Tgfbr3) with statistically significant lower 
expression levels following use of the P2 unit.  There was a statistically significant 
upregulation of 1 gene (Egf) following osteotomy preparation with P1, but not with P2 
preparation. 
 
Immunohistochemistry 
MMP2.  Sham surgeries  At 1 week (Figure 3a) post-surgery, MMP2-positive cells 
were present lining the inner cortical bone with the exception of the cells immediately 
adjacent to the surgical site.  Immunopositive cells were present lining the Haversian canals 
of the bone at the interface between osteoblasts and the bony matrix.  A notable gradient of 
immunopositive cells was identified, with a greater number of immunopositive cells present 
in the outer aspect of the bony bridge relative to the inner aspect.  Osteocytes were negative.  
Uniform bone marrow immunopositivity was present with megakaryocytes in the marrow 
immunopositive for MMP2.  Immunoreactivity was present in the fibroblasts of the soft 
tissue overlying the apparent S site.  Similar findings were noted at 3 weeks (Figure 3b) post-
surgery with the exception of the presence of immunoreactive cells lining the inner aspect of 
the S sites, a finding that was not present at 1 week.  Furthermore, the amount of reactive 
cells at 3 weeks had decreased substantially relative to the 1 week samples.  Treatment 
groups  Similar patterns of reactivity were noted at 1 (Figure 3a) and 3 weeks (Figure 3b) 
relative to S controls.  Decreased reactivity appeared present in the overlying soft tissue 
fibroblasts of P1 and P2 relative to S at 1 and 3 weeks.  At 3 weeks, decreased reactivity of R 
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was also noted relative to S.  No difference in reactivity was evident in osteotomy sites 
relative to the bone immediately adjacent to the osteotomy defect.  Minimal differences in 
reactivity were noted between the three treatment groups at 1 and 3 weeks.   
MMP8.  Sham surgeries  At 1 week (Figure 4a) and 3 weeks (Figure 4b) post-
surgery, MMP8-positive cells had a presentation remarkably similar to the MMP2-positive 
cells.  MMP8 cells circumferentially lined the inner cortical bone, including the cells 
immediately beneath the surgical site.  In the surgical site, positive cells were present lining 
the Haversian canals of the bony bridge spanning the bone with a greater number of 
immunopositive cells present in the outer aspect of the bone relative to the inner aspect.  
Osteocytes were negative.  Uniform bone marrow immunopositivity was present with a 
weaker reactivity relative to the MMP2- and TNF-α-positive cells.  Unlike MMP2 
immunostaining, no megakaryocyte reactivity was identified within the marrow space or in 
other surrounding tissues.  Osteoblasts associated with the overlying periosteum were 
immunoreactive.  Additionally, with the exception of P1 and P2 at 3 weeks, there was 
slightly less reactivity identified in the overlying soft tissue fibroblasts relative to the MMP2-
positive cells.  Treatment groups  Similar findings were noted at 1 (Figure 4a) and 3 weeks 
(Figure 4b) relative to S controls with the exception of the absence of reactivity of the cells 
lining the osteotomy defect.  While there were no reactive cells lining the stromal aspect of 
the newly formed bony bridge, a gradient of reactive cells within the newly formed bony 
bridge was identified similar to the S specimens.  Decreased reactivity that appeared present 
in the overlying soft tissues of P1 and P2 relative to S at 1 week was no longer apparent at 3 
weeks.  At 3 weeks, decreased reactivity of R was noted relative to S.   
12 
 
TNF-α.  Sham surgeries  At 1 week post-surgery (Figure 5a), TNF-α-positive cells 
had a presentation similar to the MMP2- and MMP8-positive cells.  Cells expressing TNF-α 
lined the inner cortical bone circumferentially.  Similar to the MMP2 and MMP8 staining 
patterns, a gradient of cell reactivity was present in the Haversian canals adjacent to the 
surgical site with increased cell reactivity present on the outer aspect of the bony bridge 
relative to the inner aspect.  Osteocytes were negative.  Uniform non-specific bone marrow 
positivity was present.  Very few fibroblasts in the overlying soft tissues were positive for 
TNF-α.  Minimal differences in reactivity were noted at 3 weeks post-surgery (Figure 5b).   
Treatment groups  Similar reactivity patterns were noted at 1 and 3 weeks relative to S 
controls.  Decreased fibroblastic reactivity was noted in all three treatment groups at 1 week 
relative to S controls, but not at 3 weeks.  Bone marrow reactivity was visibly more 
significant in the treatment groups relative to S, with no notable differences in reactivity 
present among the different treatment groups.  
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Table 1.  Gene Table.  Genes with significant differential expression in mechanical osteotomies using 
the different surgical modalities at 1 week post-surgery. 
Gene 
Abbreviation 
Gene  
Name 
Gene Ontology  
Term* 
Cell-Matrix Adhesion Proteins 
Itga3 Integrin, alpha 3 Cell adhesion 
Itgam Integrin, alpha M Cell adhesion 
Itgav Integrin, alpha V Cell adhesion 
Itgb1 Integrin, beta 1 Cell adhesion 
Cytokines 
Tnf Tumor necrosis factor Inflammatory response 
ECM Proteases 
Mmp2 Matrix metallopeptidase 2 Tissue remodeling 
Mmp8 Matrix metallopeptidase 8 Proteolysis 
Growth Factors 
Bmp4 Bone morphogenetic protein 4 Osteoblast differentiation 
Bmp6 Bone morphogenetic protein 6 Osteoblast differentiation 
Bmp7 Bone morphogenetic protein 7 Positive regulation of osteoblast differentiation 
Gdf10 Growth differentiation factor 10 Regulation of ossification 
Igf1 Insulin-like growth factor 1 Positive regulation of osteoblast differentiation 
Tgfb1 Transforming growth factor, beta 1 Wound healing 
Tgfb3 Transforming growth factor, beta 3 Positive regulation of bone mineralization 
Vegfa Vascular endothelial growth factor A Angiogenesis 
Extracellular Matrix Proteins 
Bgn Biglycan Blood vessel remodeling 
Col3a1 Collagen, type III, alpha 1 Collagen fibril organization 
Col4a1 Collagen, type IV, alpha 1 Epithelial cell differentiation 
Col5a1 Collagen, type V, alpha 1 Collagen fibril organization 
Col6a1 Collagen, type VI, alpha 1 Protein heterotrimerization 
Col12a1 Collagen, type XII, alpha 1 Cell adhesion 
Col14a1 Collagen, type XIV, alpha 1 Cell adhesion 
Comp Cartilage oligomeric matrix protein Extracellular matrix organization 
Fn1 Fibronectin 1 Cell adhesion 
Tuft1 Tuftelin 1 n/a 
Receptors 
Bmpr1a Bone morphogenetic protein receptor, type IA Positive regulation of bone mineralization 
Fgfr1 Fibroblast growth factor receptor 1 Chondrocyte development 
Igf1r Insulin-like growth factor 1 receptor Positive regulation of cell migration 
Scarb1 Scavenger receptor class B, member 1 Blood vessel endothelial cell migration 
Tgfbr3 Transforming growth factor, beta receptor III BMP signaling pathway 
Transcription Factors & Signaling Molecules 
Anxa5 Annexin A5 Response to organic substance 
Msx1 Msh homeobox 1 BMP signaling pathway 
Smad1 SMAD family member 1 BMP signaling pathway 
Smad3 SMAD family member 3 Osteoblast development 
*Only one biologic process gene ontology term is presented for each gene.  
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Table 2.  Gene Downregulation/Upregulation Following 1st Generation Piezotome®, 2nd Generation 
Piezotome®, or High Speed Rotary Instrumentation.  Gene expression as fold regulation following 
mechanical osteotomies using R, P1, or P2 instrumentation compared to S at 1 week post-surgery. 
 
Rotary  
Instrumentation (R) 
1st Generation  
Piezotome® (P1) 
2nd Generation  
Piezotome® (P2) 
 
Fold 
Regulation p-value 
Fold 
Regulation p-value 
Fold 
Regulation p-value 
Cell-Matrix Adhesion Proteins 
Itga3 -1.2357 0.11056 -1.5171 0.12906 -2.0458* 0.01756 
Itgam -1.0757 0.67749 -1.5670 0.22292 -1.8912* 0.01131 
Itgav 1.1132 0.27933 -1.6756* 0.02300 -1.2506 0.32323 
Itgb1 1.0410 0.66141 -1.3864* 0.02511 -1.2564 0.36985 
Cytokines 
Tnf 1.0172 0.76198 -1.4123* 0.01494 1.0872 0.63831 
ECM Proteases 
Mmp2 -1.0295 0.98403 -1.9972* 0.01874 -1.5011 0.51686 
Mmp8 -1.3398 0.19011 -1.5598 0.33539 -2.0936* 0.01208 
Growth Factors 
Bmp6 -1.1292 0.50375 -1.3361 0.14413 -1.6163* 0.04416 
Bmp7 -1.5248 0.17865 -1.4025 0.11984 -2.5245* 0.01969 
Gdf10 -1.2912 0.21974 -1.5670* 0.03276 -1.8566† 0.00964 
Igf1 1.0604 0.61550 -1.5889† 0.00459 -1.3189 0.27463 
Tgfb3 1.0362 0.73031 -1.1931* 0.01133 -1.1562 0.76492 
Vegfa -1.3967* 0.02633 1.0084 0.82389 -1.2193 0.13801 
Extracellular Matrix Proteins 
Col3a1 1.3177† 0.00783 -1.4756 0.06018 -1.0112 0.98055 
Col4a1 1.0291 0.78751 -1.7068* 0.01329 -1.4070 0.08380 
Col5a1 1.0629 0.62551 -1.4287* 0.03941 -1.1402 0.72795 
Col6a1 1.0654 0.48652 -1.9070† 0.00055 -1.5256 0.11172 
Col12a1 -1.0319 0.78660 -1.6756† 0.00738 -1.1669 0.47909 
Col14a1 1.3146 0.13309 -2.3316* 0.02379 -1.3654† 0.00219 
Comp -2.0401* 0.03725 1.0177 0.89054 -1.1887 0.58171 
Fn1 -1.0512 0.87389 -1.6563† 0.00528 -1.4006 0.11122 
Tuft1 -1.2243 0.37667 -1.9697* 0.01005 -2.1876† 0.00829 
Receptors 
Bmpr1a -1.2019 0.15650 -1.3299* 0.02704 -1.4499* 0.02509 
Fgfr1 -1.1909 0.16222 -1.4123* 0.04724 -1.4567 0.14212 
Igf1r -1.0683 0.75299 -1.4621 0.18624 -1.7045* 0.01623 
Scarb1 1.0852 0.15542 -1.3896* 0.02236 -1.2420 0.22783 
Transcription Factors & Signaling Molecules 
Smad1 -1.1991 0.20281 -1.8251† 0.00521 -1.8226* 0.01494 
Smad3 -1.4560* 0.03014 -1.2097 0.15566 -1.4433 0.07028 
*Significant difference between R, P1, or P2 instrumentation and S controls at p < 0.05.  
†Significant difference between R, P1, or P2 instrumentation and S controls at p <0.01.   
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Table 3.  Gene Downregulation/Upregulation Following 1st Generation Piezotome®, 2nd Generation 
Piezotome®, or High Speed Rotary Instrumentation.  Statistically significant differential gene 
expression following mechanical osteotomies using R, P1, or P2 instrumentation compared to S 
at 1 week post-surgery. 
Rotary  
Instrumentation (R) 
1st Generation  
Piezotome® (P1) 
2nd Generation  
Piezotome® (P2) 
downregulation upregulation downregulation upregulation downregulation upregulation 
Comp Col13a1 Bmpr1a  Bmp6  
Smad3  Col4a1  Bmp7  
Vegfa  Col5a1  Bmpr1a  
  Col6a1  Col14a1  
  Col12a1  Gdf10  
  Col14a1  Igf1r  
  Fgfr1  Itga3  
  Fn1  Itgam  
  Gdf10  Mmp8  
  Igf1  Smad1  
  Itgav  Tuft1  
  Itgb1    
  Mmp2    
  Scarb1    
  Smad1    
  Tgfb3    
  Tnf    
  Tuft1    
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Table 4.  Gene Expression Fold Regulations Following 1st Generation 
Piezotome® or 2nd Generation Piezotome® Instrumentation.  Gene 
expression as fold regulation following mechanical osteotomies using 
P1 or P2 instrumentation compared to R at 1 week post-surgery. 
 
1st Generation  
Piezotome® (P1) 
2nd Generation  
Piezotome® (P2) 
 
Fold 
Regulation p-value 
Fold 
Regulation p-value 
Cell Matrix Adhesion Proteins 
Itgam -1.4567 0.32708 -1.7581* 0.02271 
Itgav -1.8652† 0.00360 -1.3922 0.11408 
Itgb1 -1.4433† 0.00730 -1.3080 0.26900 
Growth Factors 
Bmp4 -1.5220* 0.03051 -1.6178 0.09856 
Egf 2.4691† 0.00774 1.2306 0.24125 
Igf1 -1.6849* 0.01960 -1.3986 0.22123 
Tgfb1 -1.5150 0.07687 -1.6943* 0.04703 
Extracellular Matrix Proteins 
Bgn -1.3497* 0.03881 -1.2547 0.50658 
Col3a1 -1.9444† 0.00938 -1.3324 0.08576 
Col4a1 -1.7565* 0.01171 -1.4479 0.06803 
Col5a1 -1.5185† 0.00121 -1.2120 0.54121 
Col6a1 -2.0317† 0.00261 -1.6253 0.08485 
Col12a1 -1.6238† 0.00785 -1.1308 0.58432 
Col14a1 -3.0652* 0.01979 -1.7950* 0.02776 
Receptors 
Scarb1 -1.5080* 0.01405 -1.3479 0.11515 
Tgfbr3 -1.5397* 0.02080 -1.5270* 0.04095 
Transcription Factors & Signaling Molecules 
Anxa5 -1.5256* 0.02040 -1.3510 0.23996 
Msx1 -1.5115* 0.02193 -1.6103 0.11687 
Smad1 -1.5220* 0.02419 -1.5199 0.06147 
*Significant difference between P1 or P2 and R instrumentation groups at p < 0.05.  
†Significant difference between P1 or P2 and R instrumentation groups at p <0.01. 
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Table 5.  Gene Downregulation/Upregulation Following 1st Generation Piezotome® or 
2nd Generation Piezotome® Instrumentation.  Statistically significant differential gene 
expression following mechanical osteotomies using P1 or P2 instrumentation 
compared to R at 1 week post-surgery. 
1st Generation  
Piezotome® (P1) 
2nd Generation  
Piezotome® (P2) 
downregulation upregulation downregulation upregulation 
Anxa5 Egf Col14a1  
Bgn  Itgam  
Bmp4  Tgfb1  
Col3a1  Tgfbr3  
Col4a1    
Col5a1    
Col6a1    
Col12a1    
Col14a1    
Igf1    
Itgav    
Itgb1    
Msx1    
Scarb1    
Smad1  
  
Tgfbr3 
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Figure 1.  Downregulation/Upregulation of Genes Important in Cellular Processes and Osseous 
Wound Healing following 1st Generation Piezotome®, 2nd Generation Piezotome®, or High Speed 
Rotary Instrumentation.  Numbers of genes relevant to (a) cellular processes or (b) osseous 
wound healing, as classified by Gene Ontology, up- or down-regulated following osteotomy 
creation with P1 or P2 instrumentation or with R instrumentation relative to S controls.
b 
a 
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Figure 2.  Downregulation/Upregulation of Genes Important in Cellular Processes and Osseous 
Wound Healing following 1st Generation Piezotome® or 2nd Generation Piezotome® Instrumentation.  
Numbers of genes relevant to (a) cellular processes or (b) osseous wound healing, as 
classified by Gene Ontology, up- or down-regulated following osteotomy creation with P1 or 
P2 instrumentation relative to R instrumentation.  
b 
a 
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Figure 3.  MMP2 Immunohistochemistry at 1 and 3 Weeks Post-Surgery.  
Immunohistochemistry staining with anti-MMP2 antibodies at 1 week (Figure 3a) and 3 
weeks (Figure 3b) post-surgery for the different treatment modalities and S controls. 
a 
b 
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Figure 4.  MMP8 Immunohistochemistry at 1 and 3 Weeks Post-Surgery.  
Immunohistochemistry staining with anti-MMP8 antibodies at 1 week (Figure 4a) and 3 
weeks (Figure 4b) post-surgery for the different treatment modalities and S controls.  
a 
b 
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Figure 5.  TNF-α Immunohistochemistry at 1 and 3 Weeks Post-Surgery. 
Immunohistochemistry staining with anti-TNF-α antibodies at 1 week (Figure 5a) and 3 
weeks (Figure 5b) post-surgery for the different treatment modalities and S controls. 
a 
b 
  
DISCUSSION 
 
Numerous studies have documented the clinical effectiveness of piezoelectric surgery 
( Bovi et al., 2010; Degerliyurt et al., 2009; Geha et al., 2006; Gonzalez-Garcia et al., 2008; 
Grenga & Bovi, 2004; Happe, 2007; Lee, Ahn, & Sohn, 2007; Preti et al., 2007; Sohn et al., 
2007; Sohn et al., 2009; Stubinger et al., 2006; Vercellotti, De Paoli, & Nevins, 2001; 
Vercellotti & Pollack, 2006; Wallace et al., 2007) but few have documented the cellular and 
molecular responses of bone to this form of instrumentation.  We compared the 1 week 
healing of osteotomies prepared using conventional rotary and piezoelectric instrumentation 
to surgical sham controls using a focused osteogenesis PCR array.  We also evaluated the 
osseous responses to two unique piezoelectric units and in doing so we were able to compare 
the effects of different power output capacities. Overall the results of our study demonstrate 
that gene expression linked to bone remodeling at sites prepared by rotary instrumentation 
requires a more robust genetic response relative to 1st and even the more powerful 2nd 
generation Piezotome® unit.  This indicates that gene activity associated with bone 
regeneration and remodeling at sites prepared by ultrasonic instrumentation may be activated 
at an earlier time point and/or does not require a prolonged expression pattern to support 
osseous healing as seen using rotary instrumentation.  Indeed, µCT analysis of week 3 
osteotomies indentified statistically significant increases in percent bone fill and bone 
mineral density along the peripheral aspect of the osteotomies prepared by P2 compared to R 
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suggesting differences in bone maturation rates (Part II).  Alternatively, the piezoelectric 
surgical tip itself and/or the energy imparted on it during osteotomy preparation is more 
biologically favorable relative to a round rotating bur.  To exclude the possibility of a dull 
bur contributing to osseous trauma, each osteotomy preparation using rotary instrumentation 
was performed using a fresh ¼ round bur.  Taken together, this implies that the choice of 
surgical modality impacts osseous healing rates with piezoelectric instrumentation yielding 
lower levels of bone trauma compared to traditional rotary instrumentation. 
Following injury, temporal gene expression patterns are determined by overlapping 
stages of tissue repair, largely recapitulating embryonic developmental processes 
(Gerstenfeld & Einhorn, 2003; Rundle et al., 2006).  Trauma to endochondral bones leads to 
hematoma formation and inflammation resulting in upregulation of cytokine expression.  
Cartilage formation occurs, in which extracellular matrix, angiogenic, and morphogenetic 
protein expression is upregulated.  These various proteins continue to undergo upregulation 
during primary bone formation which is coupled with cartilage resorption, resulting in further 
cytokine upregulation.  Subsequently, the bone undergoes continued remodeling processes 
(Gerstenfeld & Einhorn, 2003).  The expression of proinflammatory cytokines and matrix 
proteins in mice peaks within 24 hours of fracture, declining to very low levels 
approximately 3 days after injury.  Sequential peaks in the expression of genes important in 
the chondrogenic and osteogenic phases of remodeling occur at day 7 and at days 14-21, 
respectively (Cho, Gerstenfeld, & Einhorn, 2002).  At 7 days, our data indicate differences in 
gene expression resulting from differences in surgical modality.  To the best of our 
knowledge, no literature has been published detailing the stages of osseous healing and 
temporal gene expression patterns following experimental tibial osteotomies.  
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At 1 week, the expression of several cellular adhesion molecules (CAMs) and 
extracellular matrix (ECM) proteins were significantly decreased (p<0.05) in the P1 or P2 
groups relative to R and S reference groups.  In osseous fracture repair, expression of several 
CAM and ECM genes has been identified 11 days post-fracture, likely corresponding with 
endochondral tissue development and/or osseous replacement and formation at this stage of 
healing (Rundle et al., 2006).  Similarly, Bmp4 expression following P1 instrumentation and 
Tgfbr3 expression following P1 and P2 instrumentation are significantly diminished relative 
to R (p<0.05).  Bmp4 expression is upregulated during active osteogenesis, while the 
function of Tgfbr3 expression involves protein binding (including GDF5, BMP-2, BMP-4, 
and BMP-7) important in the chondrogenic and osteogenic phases of healing (Cho et al., 
2002; Kirkbride et al., 2008).  Relative decreases in the expression of these proteins at this 
time point following piezoelectric instrumentation, while currently unexplained, may 
possibly be related and linked to accelerated healing and/or decreased trauma.   
Immunohistochemistry was completed to confirm the translation of several genes 
(Mmp2, Mmp8, and Tnf) expressed among the three groups.  Increased protein expression 
was qualitatively identified with immunohistochemistry at 1 week relative to 3 weeks, 
consistent with previously reported expression levels of TNF-α and MMP2, but contradictory 
with levels of MMP8 previously identified in osseous fracture healing at these times points 
(Gerstenfeld et al., 2003; Lehmann et al., 2005).   
An interesting finding was the significant histological appearance of surface pitting of 
bone in the S group along areas where periosteal tissues were only reflected.  Studies 
(Brownlow et al., 2000; Fickl et al., 2011; Lobene & Glickman, 1963; Wood et al., 1972) 
have indicated that reflection of periosteal tissues triggers significant bone remodeling 
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processes and it is likely that this process contributed to osseous healing and our findings.  
Nevertheless it is important to account for tissue activity due to periosteal reflection at the 
genetic and tissue level. 
These findings, when examined in conjunction with the downstream µCT and 
histological findings described in Part II, provide further evidence that diminished levels of 
these factors following piezoelectric instrumentation may be due to an acceleration in wound 
healing and/or decreased trauma.  Differences in the rates of healing will influence the gene 
expression patterns among the different treatment groups at any particular time.  This may 
support the reduced mRNA levels of the CAMs and ECM at this time point.  Conversely, it is 
possible that the different surgical modalities may have had different effects on peripheral 
osseous structures adjacent to the osteotomy, potentially influencing not only the rate of 
healing within the osteotomy site, but also the timing, duration, and degree of gene 
expression.  Surgical modalities causing damage to peripheral osseous tissues or inducing 
peripheral bone resorption may necessitate increased gene expression levels to accommodate 
an increased need for healing.  Indeed, it is likely that piezoelectric instrumentation results in 
fewer changes to adjacent bone which may help explain the reduced levels of Bmp4 and 
Tgfbr3 mRNA at 1 week.  The effects of the different surgical modalities on peripheral 
osseous structures will be evaluated in Part II of this manuscript. 
The biological bases for our observations are not completely understood, however 
additional factors such as post-treatment bone microstructure, vascularity, inflammatory 
response, and others may impact osseous healing.   
 
  
CONCLUSIONS 
 
Following osteotomy preparation with piezoelectric instrumentation, there are 
differential expression levels of genes important in osseous healing relative to high speed 
rotary insrumentation and surgical sham controls.  Decreased mRNA levels of 18 genes after 
P1 instrumentation and 11 genes following P2 instrumentation were present when sham 
surgeries were used as a reference group.  This differential expression pattern is hypothesized 
to be related to effects of the different surgical modalities on adjacent bone structure, 
including trauma, that may influence either the rate of the healing process or the amount of 
gene expression necessary for bone healing.  Immunohistochemistry confirmed the 
expression of genes with differential expression levels, including MMP2, MMP8, and TNF-
α.  Their expression was localized to the defect areas and adjacent peripheral tissues with 
differences in expression levels present between 1 and 3 weeks.  Additional research is 
necessary to evaluate and compare gene expression levels between the three different 
treatment modalities at all stages of the bone healing process, including at 24 hours (start of 
inflammatory phase), 72 hours (end of inflammatory phase), 7 days (peak of chondrogenic 
phase), and 14-21 days (peak of osteogenic phase).  These will permit better conclusions to 
be drawn regarding differences in gene expression at different times during the healing 
process and their effect on the rate of healing.
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PART II:  
  
µCT AND HISTOLOGICAL COMPARISON OF WOUND HEALING 
RESPONSE FOLLOWING IN VIVO BONE INSTRUMENTATION WITH 
PIEZOTOME® ULTRASONIC SURGICAL UNITS AND HIGH SPEED  
ROTARY INSTRUMENTATION 
Abstract 
 This study compared the radiographic and histological wound healing responses of 
bone to piezoelectric or high speed rotary instrumentation.  Eight Sprague-Dawley rats 
underwent bilateral tibial osteotomies (n=16) prepared in a randomized split-leg design using 
high speed rotary (R) (n=7), 1st Generation Piezotome® (P1) (n=5), or 2nd Generation 
Piezotome® (P2) (n=4) instrumentation.  At 3 weeks, qualitative histologic evaluation and 
quantitative µCT analysis assessed percentage bone fill (%BF) and bone mineral density 
(BMD) in the defect, peripheral, and distant regions.  No differences in %BF or BMD were 
detected between groups within the osteotomy defect.  Significant differences in %BF 
(p=0.020) and BMD (p=0.008) were noted along the peripheral region between P2 and R 
groups.  No significant decreases in BMD were noted in peripheral sites compared to distant 
sites following piezoelectric instrumentation.  Histologically, smooth osteotomy margins 
were present following piezoelectric instrumentation.  These findings indicate that 
piezoelectric instrumentation favors preservation of bone adjacent to osteotomies. 
 
  
INTRODUCTION 
 
The piezoelectric effect, where solid crystalline materials (including quartz, silica, 
and ceramic) (O'Brien, 2007; Poblete-Michel & Michel, 2009) become electrically polarized 
under mechanical stress, was first reported by Jacques and Pierre Curie in 1880.  The 
converse of this, the principle that the application of electricity to a crystalline material is 
capable of producing crystal expansion and consequent mechanical movement – the indirect 
piezoelectric effect – was later described by Gabriel Lippmann in 1881 (Katzir, 2006; 
O'Brien, 2007).  This indirect piezoelectric effect is the principal by which piezoelectric 
systems function in dental applications. 
Dental piezoelectric surgical units function by the application of electrical current to 
polarized quartz or ceramic disks oriented in the long-axis of a surgical handpiece.  When 
current is applied in an alternating fashion, the ceramic elements undergo rhythmic 
lengthening and shortening movements.  This generated mechanical energy is transmitted to 
a surgical tip attached to the handpiece, resulting in the linear movement and vibration of the 
tip.  This movement is capable of cutting through mineralized tissues.  An amplifier acts to 
increase the amount of movement and vibration within the surgical tip (Poblete-Michel & 
Michel, 2009), permitting tip vibrations commonly in the range of 60-200 µm (Schlee et al., 
2006), a degree of movement that optimizes the cutting potential. 
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There are four primary advantages of piezosurgical units, including selective cutting 
action, increased precision, improved visibility, and greater surgical accessibility (Poblete-
Michel & Michel, 2009).  First, piezoelectric surgical units oscillate at an ultrasonic 
frequency of 25 – 30 kHz, a frequency at which mineralized tissues – such as bone – are 
selectively cut while nerves, blood vessels, and other soft tissues are not injured.  A 
frequency greater than 50 kHz is required to cut these soft tissues (Schlee et al., 2006).  This 
characteristic is especially useful in a variety of surgical procedures that pose an increased 
risk of damage to soft tissues, such as lateral window sinus lifts or surgical procedures 
adjacent to nerves.  Second, piezosurgical units offer increased precision in that no 
macromovements are generated during the use of the vibrating surgical tip, permitting the 
generation of narrower and more precise cuts (Poblete-Michel & Michel, 2009).  Third, 
increased visibility is a consequence of the cavitational effect by which irrigational water 
bubbles implode, mechanically removing debris and blood (Poblete-Michel & Michel, 2009).  
Finally, improved surgical accessibility is present due to the design of the different surgical 
tips. 
Currently, there are greater than 50 articles detailing the use and advantages of 
piezoelectric surgical units in a variety of surgical treatments, including lateral window sinus 
lift techniques (Sohn et al., 2009; Vercellotti et al., 2001; Wallace et al., 2007), autogenous 
bone grafting (Happe, 2007; Sohn et al., 2007; Stubinger et al., 2006), implant site 
preparation (Preti et al., 2007), osteotomy close to nerves (Bovi et al., 2010; Geha et al., 
2006), extractions (Degerliyurt et al., 2009; Grenga & Bovi, 2004), periodontal surgery 
(Vercellotti & Pollack, 2006), and distraction osteogenesis (Gonzalez-Garcia et al., 2008; 
Lee et al., 2007).  Despite its common use in clinical practice, there is limited literature 
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published detailing the biologic wound healing response to piezoelectric surgery or any 
biological advantages of this surgical modality. 
The purpose of this present study is to compare the effects of the first- and second-
generation Piezotome® (Satelec Acteon Group, Merignac, France) surgical units on osseous 
healing to traditional high speed rotary instrumentation using radiographic and histologic 
approaches in a rat tibia model.  Our hypothesis is that the histologic and radiographic 
appearance, and general tissue regeneration responses of bone to instrumentation using first- 
and second-generation Piezotome units is equivalent or better than rotary instrumentation. 
  
MATERIALS AND METHODS 
 
Surgical Procedures 
All experimental procedures followed a protocol approved by the Institutional Animal 
Care and Use Committee at The University of North Carolina at Chapel Hill.  Eight male 
Sprague-Dawley rats (Charles River Laboratories International, Inc., Wilmington, MA) 
weighing approximately 250-300g were used for the study for a total of 16 tibiae.  Rats were 
anesthetized with an intraperitoneal injection of ketamine/xylazine and the surgical sites 
shaved and disinfected with Betadine®.  An incision was made along the medial aspect of 
each tibia.  The overlying muscle was gently separated and the periosteum elevated.  Using a 
randomized approach, a 6mm vertical osteotomy was prepared through the cortical bone in 
the medial aspect of each tibia using copious saline irrigation and either (1) the BS1 insert 
(Satelec Acteon, Merignac, France)  mounted on the Piezotome® (Acteon) surgical unit (n = 
4 tibiae) (P1 group), (2) the BS1 insert mounted on the Implant Center 2 (Piezotome® 2, 
Acteon) surgical unit (n = 5 tibia) (P2 group), or (3) a ¼  round bur (Brassler USA, 
Savannah, GA) with high speed rotary instrumentation (n = 7 tibiae, Implant Center 2, 
Acteon) (R group).  The power and irrigation settings were as follows: P1: Mode 1, 50 
mL/min irrigation; P2: Mode D1, 60 mL/min irrigation; and R: 200,000 revolutions per 
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minute, 60 mL/min irrigation.  Following surgery, the periosteal/muscle tissues were sutured 
using 5-0 chromic gut followed by closing of flaps with 4-0 silk suture.   
After 3 weeks of healing, the rats were euthanized by CO2 inhalation and cardiac 
perfusion fixation completed using 10% formalin.  Tibiae were isolated at the level of 
articulation, fixed in 10% neutral buffered formalin (NBF) for 48 hours, rinsed in phosphate 
buffered saline (PBS), and stored in 70% ethanol at 4°C.   
 
µCT Analysis 
Following fixation, tibiae were scanned using the Skyscan 1074HR microCT 
(Skyscan, Aartselaar, Belgium) and the Skyscan acquisition and the NRecon reconstruction 
software at a resolution of 20.5 µm/pixel.  Standardized scanning (40 kV source voltage, 
1000 µA source current, 540 ms exposure, 206 projections per 180° rotation) and 
reconstruction settings were used to produce cross-sectional images.  All images had a pixel 
size of 20.7µm x 20.7µm with 20.7µm distance between consecutive cross-sectional images.  
For calibration to determine bone mineral densities within regions of interest (ROIs), 
hydroxyapatite phantoms (Computerized Imaging Reference Systems, Inc., Norfolk, VA) of 
500 mg/cc and 1000mg/cc densities were utilized under identical scanning and reconstruction 
parameters.  CTAn software (Skyscan) was used to analyze the microCT scans.   
The defect midpoint was identified in the long axis of each tibia and analyses were 
completed to include the defect 2mm proximal to the midpoint and 2mm distal to the 
midpoint, for a total defect length of 4mm (194 of 511 cross-sectional images).  Three 
separate ROIs were selected for analysis representing the central defect and two peripheral 
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regions (Figure 1).  Each ROI was selected at 200% within the axial cross-section images 
approximating the margins of the cortical bone and analysis was completed on any material 
contained within the ROI.  For the ROI corresponding to the central defect, the width of the 
ROI was measured to correspond to the width of the instrument used to create the cortical 
osteotomy (0.50mm for the ¼ round bur used in rotary instrumentation and 0.60mm for the 
BS1 insert used in Piezotome 1 and Piezotome 2 instrumentation).  Two peripheral ROIs 
with a width of 0.25mm immediately adjacent to the defect ROI were evaluated to assess the 
effects of the different instrumentation methods on peripheral bone.  A distant ROI with a 
width of 0.25mm on a surface without periosteal soft tissue elevation or osteotomy 
preparation was also evaluated to compare the effects of different instrumentation methods 
on distant bone.  Bone volume fraction (BV/TV) and the average volumetric mineral density 
of the mineralized tissue (BMD in mg/cc) were quantified.  For each sample, the values for 
the two peripheral regions were averaged prior to statistical analyses. 
 
Histology 
Tissues fixed in 10% NBF were rinsed in PBS and demineralized by immersion in 
Immunocal (Decal Chemical Corporation, Tallman, NY) for 2 weeks at room temperature.  
Complete decalcification was confirmed by lack of radiopacity using additional microCT 
scans.  Tissues were processed with routine ethanol dehydrations, xylene clearing, and 
paraffin infiltrations.  Specimens were axially sectioned at a thickness of 5 µm, 
deparaffinized, and stained with hematoxylin and eosin for gross light microscopic analysis.  
Samples were qualitatively assessed. 
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Statistics 
Statistical analyses of microCT data was performed using SPSS 17.0 software (SPSS, 
Inc., Chicago, IL).   The one-way ANOVA statistical test was used to evaluate differences in 
the percentage of bone fill and bone mineral density in the defect and peripheral ROIs.  
Tukey post-hoc analysis was used to identify statistically significant differences (p-values ≤ 
0.05) between the groups.  Data is presented as mean ± standard deviation. 
  
RESULTS 
 
Safety 
All rats healed unremarkably with no detectable differences in healing or notable 
post-operative discomfort identified between the groups throughout the duration of the three 
week healing period.  Histologically, there was no evidence of any exuberant inflammatory 
events, with no notable differences in the inflammatory response between groups.  Similarly, 
there was no evidence of any pathological features radiographically.  
 
Percentage of Bone Fill (%) in Osteotomy Defect, Immediately Adjacent Periphery, and 
Distant Regions 
In the central osteotomy defect regions, there were no statistically significant 
differences (p = 0.830) in the percentage of bone fill (%BF) following instrumentation with 
P1 (31.63 ± 15.94%), P2 (36.87 ± 15.64%), and R (32.73 ± 11.56%).  However, compared to 
R (59.43 ± 12.89%), there was a statistically significant increase in the percentage of bone 
fill in the peripheral region immediately adjacent to the central osteotomy following 
instrumentation with P2 (79.70 ± 10.32%; p = 0.020), but not with P1 (72.13 ± 7.50%; p = 
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0.198).  There was no statistically significant difference in percentage of bone fill between P1 
and P2 treatment groups (p = 0.577) (Table 1 & Figure 2).   
Relative to distant regions, there were statistically significant differences in the 
percentage of bone fill in the central osteotomy defect and immediately peripheral regions for 
all three treatment groups (Table 2 & Figure 2). 
 
Bone Mineral Density (mg/cc) in Osteotomy Defect, Immediately Adjacent Periphery, 
and Distant Regions 
In the central osteotomy defect regions, there were no statistically significant 
differences in bone mineral density between the three treatment groups (P1: 0.51 ± 0.17 
mg/cc; P2: 0.60 ± 0.13 mg/cc; R: 0.55 ± 0.10 mg/cc; p = 0.607).  However, similar to percent 
bone fill, there was a statistically significant increase in the bone mineral density in the 
peripheral region immediately adjacent to the central osteotomy following instrumentation 
with P2 (0.98 ± 0.08 mg/cc; p = 0.008) compared to R (0.79 ± 0.10 mg/cc), but not with the 
P1 (0.90 ± 0.08 mg/cc; p=0.160).  Similarly, there was no statistically significant difference 
in bone mineral density between P1 and P2 treatment groups (p = 0.403) (Table 1 & Figure 
3). 
Relative to distant regions, there were statistically significant differences in the bone 
mineral density of the central osteotomy defect for all three treatment groups.  However, 
there was a statistically significant decrease in the bone mineral density only between the 
immediately adjacent periphery and distant regions following rotary instrumentation (p < 
0.0001). 
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Equivalence Testing 
For each region of interest, equivalence testing was completed using 95% confidence 
intervals compared to a zone of clinical indifference determined by the standard deviation 
following rotary instrumentation (Appendix A).  Equivalence testing supports the statistical 
analyses, indicating that the three treatment groups are equivalent in regards to percentage of 
bone fill and bone mineral density in the central osteotomy and distant sites.  Non-
equivalence, however, is suggested between rotary R and P2 in regards to bone mineral 
density in sites peripheral to the osteotomy. 
 
Descriptive Histology of Bone Healing 
Histologically, the healing of the osteotomies was very similar between the P1 and P2 
groups at 3 weeks.  Bone healing correlated with radiographic findings (Figure 4).  
Furthermore, there were minimal differences apparent in the quality of the regenerated bone 
within the osteotomy defects following the three different treatment modalities.  In a number 
of sections in which rotary instrumentation was performed (Figure 5), the remodeling process 
appeared to extend laterally relative to the osteotomy site, a feature not characteristic of the 
osteotomy sites prepared by piezoelectric instrumentation.  Following P1 (Figure 6) or P2 
(Figure 7) instrumentation, the osteotomy margins were smooth and much better defined in a 
majority of the samples at 3 weeks, suggesting minimal post-operative necrosis of the 
marginal bone during the healing process following piezoelectric instrumentation.  This 
feature was inconsistently identified in the samples following rotary instrumentation.  In all 
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samples, osteoblasts lined the inner aspect of the bone, including the newly formed bone 
within the defect.  Incremental lines were present, indicating bone apposition, and minimal 
inflammatory cells were also present at 3 weeks. 
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Figure 1.  ROI Selections for µCT Analysis.  µCT cross-section of the tibiae 3 weeks after 
ultrasonic osteotomy preparation demonstrating measured ROI selections for µCT analysis 
with the CTAn software.  The width of the Defect ROI was 0.50mm for R instrumentation 
and 0.60mm for both P1 and P2 instrumentation.  The width of the Periphery 1, Periphery 2, 
and Distant ROIs was 0.25mm.  Each peripheral ROI (left and right) was analyzed separately 
with the mean value of each sample used for analysis. 
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 Figure 2.  Percentage of Bone Fill at 3 Weeks.  µCT analysis of the bone fill (mean (%) ± 
standard deviation) at 3 weeks post-surgery in the central defect, periphery, and distant 
region of interests (ROIs) following osteotomy with P1, P2, and R instrumentation. 
*Significant difference between treatment groups at p < 0.05.  †Significant difference between 
treatment groups at p < 0.01.  
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Figure 3.  Bone Mineral Density (mg/cc) at 3 Weeks.  µCT analysis of bone mineral density 
(mean (mg/cc) ± standard error) at 3 weeks post-surgery in the central defect and periphery 
region of interests (ROIs) following osteotomy with P1, P2, and R instrumentation.  
*Significant difference between treatment groups at p < 0.05.  †Significant difference between 
treatment groups at p < 0.01. 
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Figure 4.  Radiographic and Histologic Signs of Healing at 3 Weeks Post-Surgery.  Bone 
healing identified histologically within the osteotomy defect correlated with radiographic 
findings at 3 weeks. 
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Figure 5.  Histology following High Speed Rotary Instrumentation.  Following 
instrumentation with R, osteotomy surfaces are largely irregular with some samples 
exhibiting smooth surfaces.  Furthermore, peripheral regions appear to have greater 
resorption and osseous irregularities relative to samples with P1 or P2 instrumentation. 
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Figure 6.  Histology following 1st Generation Piezotome® Instrumentation.  Following 
instrumentation with P1, smooth osteotomy surfaces are present with newly formed bone 
either adjacent to or in immediate contact with the osteotomy surface.  Arrowheads are used 
to denote the smooth osteotomy margins.  
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Figure 7.  Histology following 2nd Generation Piezotome® Instrumentation.  Following 
instrumentation with P2, smooth osteotomy surfaces are present with newly formed bone 
either adjacent to or in immediate contact with the osteotomy surface.  Arrowheads are used 
to denote the smooth osteotomy margins.   
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Table 1.  Percentage of Bone Fill and Bone Mineral Density (mg/cc) at 3 week within Different 
ROI Locations.  µCT data (mean ± standard deviation) for bone fill (%) and bone mineral 
density (mg/cc) in the central osteotomy defects, immediately adjacent peripheral bone, and 
distant regions at 3 weeks post-surgery.   
 
DEFECT PERIPHERY DISTANT 
 
Bone Fill (%) 
Bone Mineral 
Density 
(mg/cc) 
Bone Fill (%) 
Bone Mineral 
Density 
(mg/cc) 
Bone Fill (%) 
Bone Mineral 
Density 
(mg/cc) 
1st Generation  
Piezotome® (P1) 
 (n=4) 
31.63 ± 
15.94 0.51 ± 0.17 
72.13 ±  
7.50 0.90 ± 0.08 
97.51 ±  
2.32 1.02 ± 0.10 
2nd Generation  
Piezotome® (P2) 
 (n = 5) 
36.87 ± 
15.64 0.60 ± 0.13 
79.70 ± 
10.32* 0.98 ± 0.08
†
 
98.18 ±  
0.90 1.07 ± 0.08 
Rotary 
Instrumentation (R)  
(n = 7) 
32.73 ± 
11.56 0.55 ± 0.10 
59.43 ± 
12.89 
0.79 ± 0.10 98.68 ±  
1.50 1.07 ± 0.07 
*
 p < 0.05 within location compared to R.  † p < 0.01 within location compared to R. 
Table 2.  Percentage of Bone Fill and Bone Mineral Density (mg/cc) at 3 week within Treatment 
Groups.  µCT data (mean ± standard deviation) for bone fill (%) and bone mineral density 
(mg/cc) in the central osteotomy defects,  immediately adjacent peripheral bone, and distant 
regions at 3 weeks post-surgery.   
 
DEFECT PERIPHERY DISTANT 
 
Bone Fill (%) 
Bone Mineral 
Density 
(mg/cc) 
Bone Fill (%) 
Bone Mineral 
Density 
(mg/cc) 
Bone Fill (%) 
Bone Mineral 
Density 
(mg/cc) 
1st Generation  
Piezotome® (P1)  
(n=4) 
31.63 ± 
15.94† 0.51 ± 0.17
†
 
72.13 ±  
7.50* 0.90 ± 0.08 
97.51 ±  
2.32 1.02 ± 0.10 
2nd Generation  
Piezotome® (P2)  
(n = 5) 
36.87 ± 
15.64† 0.60 ± 0.13
†
 
79.70 ± 
10.32* 0.98 ± 0.08 
98.18 ±  
0.90 1.07 ± 0.08 
Rotary 
Instrumentation (R)  
(n = 7) 
32.73 ± 
11.56† 0.55 ± 0.10
†
 
59.43 ± 
12.89† 
0.79 ± 0.10† 98.68 ±  
1.50 1.07 ± 0.07 
*
 p < 0.05 within treatment group compared to distant location.  † p < 0.01 within treatment 
group compared to distant location. † 
  
DISCUSSION 
 
While the clinical effectiveness of piezoelectric surgery continuous to be well 
documented, the tissue response to this form of surgical instrumentation is not completely 
understood.  We compared the osseous healing responses to osteotomies prepared using 
piezoelectric and conventional rotary instrumentation using radiographic and histological 
techniques and also compared two piezoelectric surgical units with different power output 
capacities.  The rationale for the latter comparison is to assess the potential for tissue damage 
at the higher power output. 
There were no detectable differences in healing and animal behavior after 
instrumentation with any of the three different treatment modalities throughout the duration 
of the healing period.  When we evaluated percent bone fill and bone mineral density at the 
central and peripheral aspects of the osteotomies, there was a significant increase in the 
percentage of bone fill and bone mineral density in the peripheral region immediately 
adjacent to the osteotomy, but not in the central aspect of the osteotomy following 
instrumentation with P2 relative to R.  When compared to bone at distant regions, there were 
no statistical differences in bone mineral density between the central region of the osteotomy 
site between groups.  However, there were statistically significant differences in bone 
mineral density along the periphery of the osteotomy compared to the R group, indicating 
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less mineralization of bone at sites instrumented with R relative to P1 or P2.  Histologically, 
the margins of the osteotomy surfaces were exceptionally smooth following piezoelectric 
instrumentation.   
Concerns that the added power in the P2 unit may be detrimental to osseous tissues, 
potentially impeding the osseous healing process, are not supported by this study.  Previous 
studies have described factors that may influence osseous healing include temperature, post-
instrumentation microstructure, and blood perfusion (von See et al., 2011).  Bone necrosis 
occurs during osteotomy preparation when the bone temperature exceeds 47°C for 1 minute 
(Albrektsson & Eriksson, 1985).  Harder et al. (2009), reported first generation Piezotome® 
units produced a median temperature increase of 1.2°C, while other ultrasonic piezoelectric 
units examined produced median temperature increases of 2.5-3.1°C on bone specimens at 
room temperature (21°C), well below the 47°C threshold.  In these laboratory conditions, the 
bone temperature increases during piezoelectric instrumentation are below that necessary to 
cause necrosis.  While a benefit of piezoelectric surgery is improved visibility of the surgical 
site due to the cavitation effect, we did not find histologic evidence of intraosseous vascular 
thrombosis or occlusion of adjacent bone that might occur following piezoelectric 
instrumentation, which is supported by other studies (von See et al., 2011).  Consequently, 
blood supply to the remaining osseous tissue appears to be preserved.  There is no known 
evidence at this time to support the theory that the added power found in the P2 unit will 
either impair the healing process or more directly damage peripheral bone.  Although we did 
not evaluate these specific factors, the lack of tissue necrosis and the presence of a minimal 
inflammatory infiltrate in samples instrumented at the higher power output suggest that they 
were minimally impacted.   
53 
 
Evidence suggests that micro-cracks form during plastic deformation of bone and act 
to mechanically damage canalicular spaces and promote osteocyte apoptosis (Noble & 
Reeve, 2000; Rochefort, Pallu, & Benhamou, 2010).  Damage to canalicular spaces during 
osteotomy preparation may be expected to have a similar effect on osteocyte viability.  
Following piezoelectric ultrasonic instrumentation, bone microstructure and the vitality of 
osteocytes adjacent to the cut surface is preserved (Hollstein et al., 2011).  In normal bone 
homeostasis, osteocyte cell death promotes osteoclast recruitment and subsequent resorption 
through complex cell signaling during the initial stages of repair (Nakahama, 2010).  
Maintenance of peripheral cellular vitality may act to minimize cellular signaling processes 
contributing to osseous resorptive processes, while the intact bony margins may provide a 
solid surface for osteoblasts adherence and osteoid deposition.  Indeed, bone apposition was 
readily apparent on peripheral surfaces forming an osseous bridge spanning the outer aspect 
of the osteotomy defect.  While the defect margins were still identifiable histologically, the 
newly regenerated bone was largely in direct contact with the previously cut bone and in 
some locations indistinguishable from the preexisting bone.  While radiographic differences 
were noted in the quality of the bone within peripheral sites following R instrumentation 
relative to either P1 or P2, there were no histologically notable differences in the quality of 
the bone between P1 and P2 in either the central or peripheral osteotomy sites.  Anecdotally, 
osteotomies prepared using P2 were completed faster than with P1.  When taken together, 
these findings suggest that the increased power and speed of the P2 unit was not detrimental 
to the bone immediately adjacent to the osteotomy compared to the other instrumentation 
methods studied. 
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This radiographic and histologic study points to favorable osseous wound healing 
when piezoelectric instrumentation is used as the surgical modality, including the P2 unit 
with its higher power output capacity.  Additional studies with larger numbers of animals are 
required to confirm our findings and to further investigate the effects of piezoelectric energy 
on osseous wound healing factors at the tissue and cellular level, specifically osteocyte and 
osteoblast function. 
 
 
  
CONCLUSIONS 
 
There are no statistically significant differences in the amount of bone fill or bone 
mineral density radiographically in the central osteotomy defects following P1, P2, and R 
instrumentation at 3 weeks.  There is increased bone fill and bone mineral density in the 
region immediately peripheral to the central defect following osteotomy preparation with P2 
compared to R.  Furthermore, there are no significant differences in the bone mineral density 
between the bone immediately peripheral to the central osteotomy defects and distant sites 
following instrumentation with either P1 or P2.  Histologically, bone fill within osteotomy 
sites prepared with P1 or P2 instrumentation appear to have increased osseous organization 
and maturity relative to R instrumentation.  Additionally, no adverse effects were identified 
either radiographically or histologically following instrumentation with P1 or P2 units.  
Future studies should be aimed at confirming these findings with larger treatment groups and 
evaluating the effects of the different treatment modalities on intramembranous bone healing.
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APPENDIX A: 
Equivalence Testing Using Confidence Intervals 
 
Figure 1.  Equivalence Testing within the Defect ROI.  Equivalence testing using 95% 
confidence intervals for (a) percentage of bone fill (%) and (b) bone mineral density (mg/cc) 
in the central defect ROI between the three treatment groups following µCT analysis.  For 
each treatment group, mean ± 95% confidence interval is charted.  The dark gray zone 
represents the zone of indifference as determined by the mean ± one standard deviation 
following rotary instrumentation. 
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Figure 2.  Equivalence Testing within the Periphery ROI.  Equivalence testing using 95% 
confidence intervals for (a) percentage of bone fill (%) and (b) bone mineral density (mg/cc) 
in the periphery ROI between the three treatment groups following µCT analysis.  For each 
treatment group, mean ± 95% confidence interval is charted.  The dark gray zone represents 
the zone of indifference as determined by the mean ± one standard deviation following rotary 
instrumentation. 
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Figure 3.  Equivalence Testing within the Distant ROI.  Equivalence testing using 95% 
confidence intervals for (a) percentage of bone fill (%) and (b) bone mineral density (mg/cc) 
in the distant ROI between the three treatment groups following µCT analysis.  For each 
treatment group, mean ± 95% confidence interval is charted.  The dark gray zone represents 
the zone of indifference as determined by the mean ± one standard deviation following rotary 
instrumentation. 
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Figure 4.  Equivalence Testing following 1st Generation Piezotome® Instrumentation.  
Equivalence testing using 95% confidence intervals for (a) percentage of bone fill (%) and 
(b) bone mineral density (mg/cc) as determined by µCT analysis for the three ROI following 
osteotomy fabrication with P1.  For each treatment group, mean ± 95% confidence interval is 
charted.  The dark gray zone represents the zone of indifference as determined by the mean ± 
one standard deviation following rotary instrumentation. 
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Figure 5.  Equivalence Testing following 2nd Generation Piezotome® Instrumentation.  
Equivalence testing using 95% confidence intervals for (a) percentage of bone fill (%) and 
(b) bone mineral density (mg/cc) as determined by µCT analysis for the three ROI following 
osteotomy fabrication with P2.  For each treatment group, mean ± 95% confidence interval is 
charted.  The dark gray zone represents the zone of indifference as determined by the mean ± 
one standard deviation following rotary instrumentation. 
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Figure 6.  Equivalence Testing Following High Speed Rotary Instrumentation.  Equivalence 
testing using 95% confidence intervals for (a) percentage of bone fill (%) and (b) bone 
mineral density (mg/cc) as determined by µCT analysis for the three ROI following 
osteotomy fabrication with R.  For each treatment group, mean ± 95% confidence interval is 
charted.  The dark gray zone represents the zone of indifference as determined by the mean ± 
one standard deviation following rotary instrumentation. 
 
